Treating COVID-19

Pharmacist CEU
Contact Hours: 2.0 (0.2 CEUs)

Course Summary

This course provides an overview of the current understanding of COVID-19, its impact on the human body, and the available treatment options. Participants will learn that COVID-19 is not just a respiratory virus, but a systemic inflammatory virus that affects major organs in the body. The severity of the disease ranges considerably, with the elderly and those with comorbidities at a significantly higher risk of hospitalization and death. Treatment protocols for acute COVID-19 and long COVID will be discussed, but it will be emphasized that the research in this field is rapidly evolving, and clinicians must stay current on the latest studies and publications to provide the best care for their patients.

Course Objectives

Identify the latest research studies and publications on COVID-19 treatment and apply them to clinical practice

Describe the systemic inflammatory response to COVID-19 and how it affects major organs in the body

Compare the effectiveness and safety profiles of different COVID-19 treatments based on the latest research studies and publications

Describe long COVID symptoms and diagnosis

Discuss treatment options for long COVID

I. Introduction

II. History of COVID-19

III. Pathophysiology of SARS-CoV-2 and COVID-19

IV. COVID-19 Treatment Options

1. Antiviral Drugs
2. Monoclonal Antibodies
3. Treatments that Require Further Study

V. Treatment Based on the Severity of COVID-19

1. Asymptomatic or Presymptomatic
2. Mild Illness
3. Moderate Illness
4. Severe Illness

VI. COVID-19 Test to Treat

VII. Long COVID-19 Treatment

COVID-19 Vaccine Update

VIII. Summary

How to Earn Credit:
To earn credit for this course, participants must:
  1. Read the course objectives and faculty planner disclosure
  2. Read the course material
  3. Complete the post-test with a minimum score of 70% and complete the course evaluation form.
  4. Results are automatically submitted to CPE Monitor

Faculty Planner Disclosure

The following individuals were involved in developing this activity: Steven Malen, PharmD, MBA, and Pamela Sardo, PharmD, BS. Pamela Sardo, Pharm.D., B.S., was an employee of Rhythm Pharmaceuticals until March 2022 and has no conflicts of interest or relationships regarding the subject matter discussed. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.

Unlabeled Use Disclosures

The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of LLC. LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.

Computer Hardware/Software Requirements

Please ensure the device you plan to use meets these requirements and specifications:

  • Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
  • Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
  • A connection to the internet
  • For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.

  • Target Audience: Pharmacist
  • Contact Hours: 2.0 (0.2 CEUs)
  • Activity Release Date: 5/8/2023
  • Activity Expiration Date: 5/8/2026
  • Activity Type: Knowledge
  • UAN: 0669-0000-23-066-H01-P
  • Topic: Disease State Management/Drug Therapy
  • CeBroker Number: 20-1042880


Steve Malen, PharmD, MBA



The logo for the Accreditation Council for Pharmacy Education (ACPE)., LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

‹‹ Back to Course List